These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15350175)

  • 21. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents.
    Babapulle MN; Joseph L; Bélisle P; Brophy JM; Eisenberg MJ
    Lancet; 2004 Aug 14-20; 364(9434):583-91. PubMed ID: 15313358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perspectives of drug-eluting stents: the next revolution.
    Moses JW; Kipshidze N; Leon MB
    Am J Cardiovasc Drugs; 2002; 2(3):163-72. PubMed ID: 14727979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymer-based paclitaxel-eluting coronary stents. Clinical results in de novo lesions.
    Chieffo A; Colombo A
    Herz; 2004 Mar; 29(2):147-51. PubMed ID: 15054587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-eluting stent: the emerging technique for the prevention of restenosis.
    Sheiban I; Carrieri L; Catuzzo B; Destefanis P; Oliaro E; Moretti C; Trevi GP
    Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trials.
    Weissman NJ; Ellis SG; Grube E; Dawkins KD; Greenberg JD; Mann T; Cannon LA; Cambier PA; Fernandez S; Mintz GS; Mandinov L; Koglin J; Stone GW
    Eur Heart J; 2007 Jul; 28(13):1574-82. PubMed ID: 17540849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coated stents to prevent restenosis in coronary heart disease.
    Gorenoi V; Dintsios CM; Hagen A
    GMS Health Technol Assess; 2005 Nov; 1():Doc06. PubMed ID: 21289927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug-eluting stents do they make the difference? ].
    Presbitero P; Asioli M
    Minerva Cardioangiol; 2002 Oct; 50(5):431-42. PubMed ID: 12384625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-eluting stents: from randomized trials to the real world.
    Saia F; Degertekin M; Lemos PA; Serruys PW
    Minerva Cardioangiol; 2004 Oct; 52(5):349-63. PubMed ID: 15514571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.
    Dibra A; Kastrati A; Mehilli J; Pache J; Schühlen H; von Beckerath N; Ulm K; Wessely R; Dirschinger J; Schömig A;
    N Engl J Med; 2005 Aug; 353(7):663-70. PubMed ID: 16105990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization: one-year results from the SCORE randomized trial.
    Grube E; Lansky A; Hauptmann KE; Di Mario C; Di Sciascio G; Colombo A; Silber S; Stumpf J; Reifart N; Fajadet J; Marzocchi A; Schofer J; Dumas P; Hoffmann R; Guagliumi G; Pitney M; Russell ME;
    J Am Coll Cardiol; 2004 Oct; 44(7):1368-72. PubMed ID: 15464315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study.
    Latib A; Colombo A; Castriota F; Micari A; Cremonesi A; De Felice F; Marchese A; Tespili M; Presbitero P; Sgueglia GA; Buffoli F; Tamburino C; Varbella F; Menozzi A
    J Am Coll Cardiol; 2012 Dec; 60(24):2473-80. PubMed ID: 23158530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans.
    Virmani R; Liistro F; Stankovic G; Di Mario C; Montorfano M; Farb A; Kolodgie FD; Colombo A
    Circulation; 2002 Nov; 106(21):2649-51. PubMed ID: 12438288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical studies with paclitaxel - eluting stent systems.
    Bajaj NR; Garratt KN
    Curr Pharm Des; 2010; 16(36):4025-36. PubMed ID: 21208184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis: immediate and long-term clinical and angiographic outcome.
    Liistro F; Stankovic G; Di Mario C; Takagi T; Chieffo A; Moshiri S; Montorfano M; Carlino M; Briguori C; Pagnotta P; Albiero R; Corvaja N; Colombo A
    Circulation; 2002 Apr; 105(16):1883-6. PubMed ID: 11997271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trial.
    Moses JW; Mehran R; Nikolsky E; Lasala JM; Corey W; Albin G; Hirsch C; Leon MB; Russell ME; Ellis SG; Stone GW
    J Am Coll Cardiol; 2005 Apr; 45(8):1165-71. PubMed ID: 15837244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial.
    Stone GW; Ellis SG; Cox DA; Hermiller J; O'Shaughnessy C; Mann JT; Turco M; Caputo R; Bergin P; Greenberg J; Popma JJ; Russell ME;
    Circulation; 2004 Apr; 109(16):1942-7. PubMed ID: 15078803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation.
    Herdeg C; Göhring-Frischholz K; Haase KK; Geisler T; Zürn C; Hartmann U; Wöhrle J; Nusser T; Dippon J; May AE; Gawaz M
    Circ Cardiovasc Interv; 2009 Aug; 2(4):294-301. PubMed ID: 20031731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents.
    Werner GS; Krack A; Schwarz G; Prochnau D; Betge S; Figulla HR
    J Am Coll Cardiol; 2004 Dec; 44(12):2301-6. PubMed ID: 15607390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Five-year clinical outcomes of a polymer-free sirolimus-eluting stent versus a permanent polymer paclitaxel-eluting stent: final results of the intracoronary stenting and angiographic restenosis - test equivalence between two drug-eluting stents (ISAR-TEST) trial.
    King L; Byrne RA; Mehilli J; Schömig A; Kastrati A; Pache J
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):E23-8. PubMed ID: 22431239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis.
    Airoldi F; Briguori C; Iakovou I; Stankovic G; Biondi-Zoccai G; Carlino M; Chieffo A; Montorfano M; Cosgrave J; Michev I; Rogacka R; Sangiorgi GM; Colombo A
    Am J Cardiol; 2006 Apr; 97(8):1182-7. PubMed ID: 16616023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.